1. Home
  2. BCAB vs PTLE Comparison

BCAB vs PTLE Comparison

Compare BCAB & PTLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCAB
  • PTLE
  • Stock Information
  • Founded
  • BCAB 2007
  • PTLE 2013
  • Country
  • BCAB United States
  • PTLE Singapore
  • Employees
  • BCAB N/A
  • PTLE N/A
  • Industry
  • BCAB Medicinal Chemicals and Botanical Products
  • PTLE Oil Refining/Marketing
  • Sector
  • BCAB Health Care
  • PTLE Energy
  • Exchange
  • BCAB Nasdaq
  • PTLE Nasdaq
  • Market Cap
  • BCAB 19.9M
  • PTLE 16.4M
  • IPO Year
  • BCAB 2020
  • PTLE 2024
  • Fundamental
  • Price
  • BCAB $0.33
  • PTLE $0.20
  • Analyst Decision
  • BCAB Buy
  • PTLE
  • Analyst Count
  • BCAB 2
  • PTLE 0
  • Target Price
  • BCAB $1.00
  • PTLE N/A
  • AVG Volume (30 Days)
  • BCAB 811.8K
  • PTLE 1.1M
  • Earning Date
  • BCAB 08-11-2025
  • PTLE 02-21-2025
  • Dividend Yield
  • BCAB N/A
  • PTLE N/A
  • EPS Growth
  • BCAB N/A
  • PTLE N/A
  • EPS
  • BCAB N/A
  • PTLE N/A
  • Revenue
  • BCAB $11,000,000.00
  • PTLE $98,133,646.00
  • Revenue This Year
  • BCAB N/A
  • PTLE N/A
  • Revenue Next Year
  • BCAB N/A
  • PTLE N/A
  • P/E Ratio
  • BCAB N/A
  • PTLE N/A
  • Revenue Growth
  • BCAB N/A
  • PTLE N/A
  • 52 Week Low
  • BCAB $0.24
  • PTLE $0.17
  • 52 Week High
  • BCAB $2.53
  • PTLE $15.78
  • Technical
  • Relative Strength Index (RSI)
  • BCAB 38.71
  • PTLE N/A
  • Support Level
  • BCAB $0.33
  • PTLE N/A
  • Resistance Level
  • BCAB $0.37
  • PTLE N/A
  • Average True Range (ATR)
  • BCAB 0.04
  • PTLE 0.00
  • MACD
  • BCAB -0.00
  • PTLE 0.00
  • Stochastic Oscillator
  • BCAB 5.26
  • PTLE 0.00

About BCAB BioAtla Inc.

BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.

About PTLE PTL LTD Ordinary Shares

PTL Ltd is a holding company. Through its subsidiaries, it is an established bunkering facilitator providing marine fuel logistics services for vessel refuelling, primarily serving the Asia Pacific market. As a bunker facilitator, the Group's services mainly involve facilitating with its suppliers to supply fuel for the use by the customers' vessels at various ports along their voyages in the Asia Pacific region; arranging vessel refuelling activities at competitive pricing to the customers; offering trade credit to the customers for vessel refuelling; handling unforeseeable circumstances faced by the customers and providing contingency solutions to the customers in a timely manner; and handling disputes, mainly in relation to quality and quantity issues on marine fuel, if any.

Share on Social Networks: